Harnessing nanoparticles for immunomodulation and vaccines
The first successful use of nanoparticles (NPs) for vaccination was reported almost 40 years ago with a virus-like particle-based vaccine against Hepatitis B. Since then, the term NP has been expanded to accommodate a large number of novel nano-sized particles engineered from a range of materials. T...
Main Authors: | Gomes, AC, Mohsen, M, Bachmann, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2017
|
Similar Items
-
Harnessing Nanoparticles for Immunomodulation and Vaccines
by: Ariane C. Gomes, et al.
Published: (2017-02-01) -
Harnessing immunomodulation during DNA damage in Ewing sarcoma
by: Jessica D. Daley, et al.
Published: (2022-11-01) -
Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles
by: Ashutosh Pandey, et al.
Published: (2022-09-01) -
Carbonate apatite nanoparticles: A novel nano-adjuvant for oral mucosal vaccines and immunomodulator
by: Andari Sarasati, et al.
Published: (2023-07-01) -
THEME: “Vaccines and Vaccine Adjuvants/Immunomodulators for Infectious Diseases”
by: Sruthi Vijaya Retnakumar, et al.
Published: (2023-02-01)